Sanara MedTech Return on Tangible Equity 2014-2025 | SMTI
Current and historical return on tangible equity values for Sanara MedTech (SMTI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Sanara MedTech Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.04B | $-0.02B | 608.00% |
| 2025-06-30 | $-0.01B | $-0.01B | 366.67% |
| 2025-03-31 | $-0.01B | $-0.01B | 650.00% |
| 2024-12-31 | $-0.01B | $0.01B | 1100.00% |
| 2024-09-30 | $-0.01B | $-0.01B | 180.00% |
| 2024-06-30 | $-0.01B | $-0.01B | 147.37% |
| 2024-03-31 | $-0.01B | $-0.01B | 285.71% |
| 2023-12-31 | $0.00B | $0.00B | -320.00% |
| 2023-09-30 | $-0.01B | $-0.01B | -200.00% |
| 2023-06-30 | $-0.01B | $0.01B | -106.67% |
| 2023-03-31 | $-0.01B | $0.01B | -54.05% |
| 2022-12-31 | $-0.01B | $0.01B | -51.85% |
| 2022-09-30 | $-0.01B | $0.01B | -38.89% |
| 2022-06-30 | $-0.01B | $0.01B | -34.78% |
| 2022-03-31 | $-0.01B | $0.02B | -36.70% |
| 2021-12-31 | $-0.01B | $0.03B | -27.35% |
| 2021-09-30 | $0.00B | $0.03B | -16.84% |
| 2021-06-30 | $0.00B | $0.03B | -17.65% |
| 2021-03-31 | $0.00B | $0.03B | -30.77% |
| 2020-12-31 | $0.00B | $0.00B | -133.33% |
| 2020-09-30 | $-0.01B | $0.00B | -142.86% |
| 2020-06-30 | $-0.01B | $0.00B | -222.22% |
| 2020-03-31 | $0.00B | $0.01B | -266.67% |
| 2019-12-31 | $0.00B | $0.01B | 0.00% |
| 2019-09-30 | $0.00B | $0.00B | 100.00% |
| 2019-06-30 | $0.00B | $0.00B | 0.00% |
| 2019-03-31 | $0.00B | $0.00B | 0.00% |
| 2018-12-31 | $0.00B | $0.00B | 0.00% |
| 2018-09-30 | $0.00B | $0.00B | 0.00% |
| 2018-06-30 | $0.00B | $0.00B | 0.00% |
| 2018-03-31 | $0.00B | $0.00B | 0.00% |
| 2017-12-31 | $0.00B | $0.00B | 0.00% |
| 2017-03-31 | $0.00B | 400.00% | |
| 2016-06-30 | $0.00B | 400.00% | |
| 2016-03-31 | $0.00B | 400.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.173B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.832B | 21.65 |
| EssilorLuxottica (ESLOY) | France | $143.666B | 0.00 |
| Stryker (SYK) | United States | $140.007B | 26.84 |
| Medtronic (MDT) | Ireland | $129.330B | 17.92 |
| Boston Scientific (BSX) | United States | $109.879B | 24.30 |
| Medline (MDLN) | United States | $58.579B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.565B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.845B | 17.17 |
| ResMed (RMD) | United States | $35.798B | 23.90 |
| Agilent Technologies (A) | United States | $35.321B | 22.38 |
| Koninklijke Philips (PHG) | Netherlands | $30.245B | 17.95 |
| Terumo (TRUMY) | Japan | $19.677B | 22.23 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.863B | 11.61 |
| Insulet (PODD) | United States | $16.941B | 52.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.096B | 0.00 |
| Baxter (BAX) | United States | $9.618B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.888B | 29.48 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.731B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $4.557B | 13.88 |
| BillionToOne (BLLN) | United States | $4.105B | 0.00 |
| ICU Medical (ICUI) | United States | $3.506B | 22.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.168B | 14.95 |
| Haemonetics (HAE) | United States | $2.679B | 11.72 |
| Neogen (NEOG) | United States | $2.345B | 51.33 |
| Phibro Animal Health (PAHC) | United States | $2.078B | 18.31 |
| Perrigo (PRGO) | Ireland | $1.979B | 4.96 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.54 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.612B | 11.20 |
| Kestra Medical Technologies (KMTS) | United States | $1.602B | 0.00 |
| AtriCure (ATRC) | United States | $1.581B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.366B | 19.78 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.321B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.082B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.039B | 308.29 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.873B | 0.00 |
| Valneva SE (VALN) | France | $0.863B | 0.00 |
| Omeros (OMER) | United States | $0.811B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.740B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 13.38 |
| Brainsway (BWAY) | Israel | $0.444B | 75.63 |
| Cerus (CERS) | United States | $0.417B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.410B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.380B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.347B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.310B | 24.73 |
| Evolus (EOLS) | United States | $0.277B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 18.31 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.201B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.190B | 56.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.77 |
| Vireo Growth (VREOF) | United States | $0.173B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.169B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.146B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.126B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.70 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.097B | 0.00 |
| Biote (BTMD) | United States | $0.095B | 4.18 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 28.92 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.33 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |